Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s12026-007-8014-9.

Title:
Th17 cells: a new fate for differentiating helper T cells | Immunologic Research
Description:
Classically naïve CD4+ have been thought to differentiate into two possible lineages, T helper 1 (Th1) or T helper 2 (Th2) cells. Within this paradigm the pathogenesis of autoimmunity was suggested to predominantly relate to Th1 cells and the production of IFN-γ. However, there were many aspects of this model that did not seem to fit, not the least of which was that IFN-γ was protective in some models of autoimmunity. During the past 2 years, remarkable progress has been made to characterize a new lineage of helper T cells. Designated Th17 cells, this lineage selectively produces proinflammatory cytokines including IL-17, IL-21, and IL-22. In the mouse, the differentiation of this new lineage is initiated by TGFβ-1 and IL-6 and IL-21, which activate Stat3 and induce the expression of the transcription factor retinoic acid-related orphan receptor (RORγt). IL-23, which also activates Stat3, apparently serves to maintain Th17 cells in vivo. In human cells, IL-1, IL-6, and IL-23 promote human Th17 differentiation, but TGFβ-1 is reportedly not needed. Emerging data have suggested that Th17 plays an essential role in the host defense against extracellular bacteria and fungi and in pathogenesis of autoimmune diseases. Selectively targeting the Th17 lineage may be beneficial for the treatment of inflammatory and autoimmune diseases.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

google, scholar, article, cas, cells, immunol, interleukin, helper, cell, med, nat, pubmed, inflammation, differentiation, exp, chen, expression, human, cytokine, autoimmune, immunity, development, regulatory, nature, arthritis, production, factor, growth, mckenzie, lineage, stat, inflammatory, producing, oshea, autoimmunity, retinoic, receptor, role, regulates, murphy, research, induce, transforming, laurence, distinct, flavell, induction, dendritic, biol, foxp,

Topics {✒️}

il-17-secreting t-helper phenotype month download article/chapter transforming growth factor-beta interferon-gamma-producing th1 subset cells induce cd4+cd25-foxp3 lamina propria macrophages coenen-de roo cj type ii collagen-stimulated cxc chemokine lix/cxcl5 noncanonical octamer-binding site disrupted ifn-gamma gene cell-mediated intestinal inflammation il-12p40-deficient mice cyclosporin a-sensitive mechanism peripheral cd4+cd25-naive cell-dependent experimental colitis transcription factor foxp3 cytokine receptor subunit bordetella pertussis full article pdf tgf-beta inhibits murine dendritic cells il-23-il-17 immune pathway privacy choices/manage cookies induces autoimmune inflammation anti-interleukin-12 antibody t-bet de waal malefyt de sauvage fj helicobacter hepaticus-induced related subjects central nervous system tumour necrosis factor induce th1 polarization cd4+cd25+ regulatory ivanov ii collagen-induced arthritis herpesvirus saimiri gene lung cxc chemokine exogenous tgf-beta cell-mediated colitis cell-dependent colitis foxp3-expressing regulatory gene-microarray analysis card9-dependent coupling reg cell growth cell differentiation mediated van den bersselaar ifn-gamma regulates inflammatory bowel disease

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Th17 cells: a new fate for differentiating helper T cells
         description:Classically naïve CD4+ have been thought to differentiate into two possible lineages, T helper 1 (Th1) or T helper 2 (Th2) cells. Within this paradigm the pathogenesis of autoimmunity was suggested to predominantly relate to Th1 cells and the production of IFN-γ. However, there were many aspects of this model that did not seem to fit, not the least of which was that IFN-γ was protective in some models of autoimmunity. During the past 2 years, remarkable progress has been made to characterize a new lineage of helper T cells. Designated Th17 cells, this lineage selectively produces proinflammatory cytokines including IL-17, IL-21, and IL-22. In the mouse, the differentiation of this new lineage is initiated by TGFβ-1 and IL-6 and IL-21, which activate Stat3 and induce the expression of the transcription factor retinoic acid-related orphan receptor (RORγt). IL-23, which also activates Stat3, apparently serves to maintain Th17 cells in vivo. In human cells, IL-1, IL-6, and IL-23 promote human Th17 differentiation, but TGFβ-1 is reportedly not needed. Emerging data have suggested that Th17 plays an essential role in the host defense against extracellular bacteria and fungi and in pathogenesis of autoimmune diseases. Selectively targeting the Th17 lineage may be beneficial for the treatment of inflammatory and autoimmune diseases.
         datePublished:2008-01-03T00:00:00Z
         dateModified:2008-01-03T00:00:00Z
         pageStart:87
         pageEnd:102
         sameAs:https://doi.org/10.1007/s12026-007-8014-9
         keywords:
             T cells
            Cytokines
            Interleukins
            Immunoregulation
            Th1
            Th2
            Th17
            Regulatory T cells
            Immunology
            Allergology
            Medicine/Public Health
            general
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-007-8014-9/MediaObjects/12026_2007_8014_Fig1_HTML.gif
         isPartOf:
            name:Immunologic Research
            issn:
               1559-0755
               0257-277X
            volumeNumber:41
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Humana Press Inc
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Zhi Chen
               affiliation:
                     name:National Institutes of Health
                     address:
                        name:Molecular Immunology and Inflammation Branch, National Institutes of Arthritis, Musculoskeletal and Skin Diseases, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Turku
                     address:
                        name:Faculty of Medicine, Institute of Biomedicine, University of Turku, Turku, Finland
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:John J. O’Shea
               affiliation:
                     name:National Institutes of Health
                     address:
                        name:Molecular Immunology and Inflammation Branch, National Institutes of Arthritis, Musculoskeletal and Skin Diseases, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Turku
                     address:
                        name:Faculty of Medicine, Institute of Biomedicine, University of Turku, Turku, Finland
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Th17 cells: a new fate for differentiating helper T cells
      description:Classically naïve CD4+ have been thought to differentiate into two possible lineages, T helper 1 (Th1) or T helper 2 (Th2) cells. Within this paradigm the pathogenesis of autoimmunity was suggested to predominantly relate to Th1 cells and the production of IFN-γ. However, there were many aspects of this model that did not seem to fit, not the least of which was that IFN-γ was protective in some models of autoimmunity. During the past 2 years, remarkable progress has been made to characterize a new lineage of helper T cells. Designated Th17 cells, this lineage selectively produces proinflammatory cytokines including IL-17, IL-21, and IL-22. In the mouse, the differentiation of this new lineage is initiated by TGFβ-1 and IL-6 and IL-21, which activate Stat3 and induce the expression of the transcription factor retinoic acid-related orphan receptor (RORγt). IL-23, which also activates Stat3, apparently serves to maintain Th17 cells in vivo. In human cells, IL-1, IL-6, and IL-23 promote human Th17 differentiation, but TGFβ-1 is reportedly not needed. Emerging data have suggested that Th17 plays an essential role in the host defense against extracellular bacteria and fungi and in pathogenesis of autoimmune diseases. Selectively targeting the Th17 lineage may be beneficial for the treatment of inflammatory and autoimmune diseases.
      datePublished:2008-01-03T00:00:00Z
      dateModified:2008-01-03T00:00:00Z
      pageStart:87
      pageEnd:102
      sameAs:https://doi.org/10.1007/s12026-007-8014-9
      keywords:
          T cells
         Cytokines
         Interleukins
         Immunoregulation
         Th1
         Th2
         Th17
         Regulatory T cells
         Immunology
         Allergology
         Medicine/Public Health
         general
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12026-007-8014-9/MediaObjects/12026_2007_8014_Fig1_HTML.gif
      isPartOf:
         name:Immunologic Research
         issn:
            1559-0755
            0257-277X
         volumeNumber:41
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Humana Press Inc
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Zhi Chen
            affiliation:
                  name:National Institutes of Health
                  address:
                     name:Molecular Immunology and Inflammation Branch, National Institutes of Arthritis, Musculoskeletal and Skin Diseases, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Turku
                  address:
                     name:Faculty of Medicine, Institute of Biomedicine, University of Turku, Turku, Finland
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:John J. O’Shea
            affiliation:
                  name:National Institutes of Health
                  address:
                     name:Molecular Immunology and Inflammation Branch, National Institutes of Arthritis, Musculoskeletal and Skin Diseases, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Turku
                  address:
                     name:Faculty of Medicine, Institute of Biomedicine, University of Turku, Turku, Finland
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Immunologic Research
      issn:
         1559-0755
         0257-277X
      volumeNumber:41
Organization:
      name:Humana Press Inc
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:National Institutes of Health
      address:
         name:Molecular Immunology and Inflammation Branch, National Institutes of Arthritis, Musculoskeletal and Skin Diseases, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
         type:PostalAddress
      name:University of Turku
      address:
         name:Faculty of Medicine, Institute of Biomedicine, University of Turku, Turku, Finland
         type:PostalAddress
      name:National Institutes of Health
      address:
         name:Molecular Immunology and Inflammation Branch, National Institutes of Arthritis, Musculoskeletal and Skin Diseases, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
         type:PostalAddress
      name:University of Turku
      address:
         name:Faculty of Medicine, Institute of Biomedicine, University of Turku, Turku, Finland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Zhi Chen
      affiliation:
            name:National Institutes of Health
            address:
               name:Molecular Immunology and Inflammation Branch, National Institutes of Arthritis, Musculoskeletal and Skin Diseases, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
               type:PostalAddress
            type:Organization
            name:University of Turku
            address:
               name:Faculty of Medicine, Institute of Biomedicine, University of Turku, Turku, Finland
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:John J. O’Shea
      affiliation:
            name:National Institutes of Health
            address:
               name:Molecular Immunology and Inflammation Branch, National Institutes of Arthritis, Musculoskeletal and Skin Diseases, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
               type:PostalAddress
            type:Organization
            name:University of Turku
            address:
               name:Faculty of Medicine, Institute of Biomedicine, University of Turku, Turku, Finland
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Molecular Immunology and Inflammation Branch, National Institutes of Arthritis, Musculoskeletal and Skin Diseases, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
      name:Faculty of Medicine, Institute of Biomedicine, University of Turku, Turku, Finland
      name:Molecular Immunology and Inflammation Branch, National Institutes of Arthritis, Musculoskeletal and Skin Diseases, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
      name:Faculty of Medicine, Institute of Biomedicine, University of Turku, Turku, Finland
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(237)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.74s.